To determine the median use of opioid analgesic in the last 24 hours prior to discharge following cesarean delivery and the feasibility of an automated inpatient report to facilitate quantity of opioids indicated for discharge. STUDY DESIGN: Previously, all cesarean deliveries received a set number of opioids at the time of discharge regardless of use while inpatient. In an effort to minimize opioid use while inpatient, a multimodal approach was taken which included the separation of acetaminophen from opioids and scheduling of acetaminophen and non-steroidal anti-inflammatory drugs with opioid use reserved for breakthrough pain. An inpatient report was created which calculated total quantity of 5mg tabs of Roxicodone used in last 24 hours prior to discharge. A 5-day supply of opioids was then prescribed which was individualized based on the last 24-hour intake with a maximum of 40 tabs given. The median, interquartile range, 90 th percentile, and percent of patients requiring zero opioids was determined. RESULTS: There were 129 patients included in this review who underwent a cesarean delivery with a median time from delivery to discharge of 57.7 hours. The median number Roxicodone 5mg tabs given in the last 24 hours prior to discharge was 2 (interquartile range 0 to 4). The 90th percentile was 7 tabs with a maximum of 14. Prior to institution of this quality improvement project, all patients were discharged with 32 tabs of 5mg Roxicodone. After implementation, the median amount was 10 tabs given at discharge with an interquartile range of 0 to 20. Fifty patients (38.8%) required no opioids for last 24 hours prior to discharge. The report was printed daily and made available for obstetric providers to aid in personalizing discharge quantity of opioids. CONCLUSION: With the use of the electronic medical record and automated inpatient narcotic use report, the quantity of opioids at the time of discharge following cesarean delivery can be easily customized with an overall reduction in the amount of opioids dispensed for home use.
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We sought to examine the association between traumatic birth and measures of mood and parenting stress through 12 months postpartum. STUDY DESIGN: We conducted a secondary analysis of participants in the Mood, Mother and Infant (MMI) Study. Women intending to breastfeed were recruited in the 3 rd trimester for a longitudinal cohort study, oversampling for women with current/past depression or anxiety. A structured clinical interview was performed at baseline to assess for history or current diagnosis of major depressive or anxiety disorders. Baseline anxiety and depression symptoms were measured using the Beck Depression Inventory (BDI) and the Spielberger Trait Anxiety Inventory (STAI). Mood was measured at baseline and monthly with the Edinburgh Postnatal Depression Scale (EPDS), and at 2, 6, and 12 months postpartum with the BDI, Spielberger State Anxiety Scale, and Parenting Stress Index e Short Form (PSI-SF). Maternal post-traumatic stress disorder (PTSD) symptoms were assessed at 2 months postpartum using the modified Perinatal PTSD Questionnaire (PPQ); birth PTSD was defined using the established threshold of PPQ score 19. We used repeated measures analysis to quantify the association between birth PTSD and postpartum mood and parenting stress through 12 months postpartum, adjusting for prenatal PPD risk and mood symptoms. RESULTS: Data were available from 209 women, of whom 15 (7.2%) had birth PTSD. Compared to women without birth PTSD, these women had higher prenatal p¼.01) and BDI (mean 18.4 vs. 8.6, p<.01) scores. In repeated measures analysis adjusting for prenatal STAI-Trait score, BDI score and PPD risk status, we found that birth PTSD was independently associated with higher postpartum EPDS (group p¼.03, group x time p¼.01), BDI (group p<.0001), state anxiety (group p¼.002, group x time p¼.01) and PSI-SF (group p¼.002) scores through 12 months postpartum (figure). CONCLUSION: In our sample, 7% of women had birth PTSD. A traumatic birth experience was associated with postpartum anxiety and depression symptoms and parenting stress, independent of prenatal risk. These findings support efforts to minimize traumatic experiences during childbirth, and to provide additional support to women who endorse PTSD symptoms following birth.
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